Altamira Therapeutics Ltd.
Q2 2026 13F Holders
Symbol
CYTOF
CUSIP
G0360L134
Type
Equity
Class
SHS
Num filings
1
Total reported value, excl. options
$0
Compare 2026 Q2 to
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
Manager
Report Date
Value ($000)
Shares
Option Type